Modern medicine and Ayurveda each carry strengths and unmet needs. INVENTAYU was set up to position Ayurveda for scientific competitiveness, effectiveness and validated growth.
A landscape of inflating costs, declining patient trust and a slowing pipeline of genuinely new chemistry has created the need for compact, integrative and evidence-oriented responses.
Average new-drug development costs continue to climb; access shrinks for huge populations.
Adverse drug reactions, side-effect burdens and avoidable harm are eroding institutional trust.
Truly novel chemistry has slowed; many therapeutic areas have not seen genuine first-in-class entrants.
Metabolic & autoimmune complexity. Modern disease is increasingly multi-system, where single-target small molecules are struggling to keep up.
The herbal and Ayurvedic market is expanding yet poorly defined : limited by inconsistent quality, weak integration and a deficit of innovation. INVENTAYU's premise is built on scientific competitiveness and effectiveness.
Therapeutic areas selected because Ayurveda has both clinical experience and biological hypotheses to contribute : and where modern medicine has the most room for help.